Wednesday, April 16, 2025

Sharp uptake in use of new weight loss and glucose-lowering medications

Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications.

from Top Health News -- ScienceDaily https://ift.tt/eDV8R6n

No comments:

Post a Comment

Major review finds vaping likely causes lung and oral cancer

Researchers have concluded that nicotine vapes are likely to cause lung and oral cancers, based on evidence ranging from human biomarkers to...